Skip to main content
  • Saved

made a Post

Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer: A single center cohort study - PubMed

Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer: A single center cohort study - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/35758368/

Deciding if patients with small (≤1 cm), node-negative, human epidermal growth factor receptor 2 (HER2) positive breast cancer should receive adjuvant systemic therapy remains a challenge. No randomized clinical trials have examined the efficacy of trastuzumab in this setting. This prospective obser ...


Relevance: Deciding if patients with small (≤1 cm), node-negative, human epidermal growth factor receptor 2 (HER2) positive breast cancer should receive adjuvant systemic therapy remains a challenge. No randomized clinical trials have examined the efficacy of trastuzumab in this setting. This prospective observational study aimed to investigate the choice of adjuvant systemic therapy in clinical practice in China.